Boston Scientific · 16 hours ago
Peripheral Interventions R&D Intern
Arbor Lakes, MN
Internship
Hybrid
Intern
$43K/yr - $74K/yrBoston Scientific is a leader in medical science, and they are seeking a Peripheral Interventions R&D Intern to join their Interventional Oncology & Embolization team. This role involves supporting and leading current product initiatives and new product development, while providing opportunities for growth and collaboration in a fast-paced environment.
Health CareMedicalMedical Device
No H1B
Responsibilities
Use your problem-solving abilities to perform meaningful engineering work
Grow your skillset through a combination of training, hands-on experience, and mentorship
Collaborate with a cross-functional team
Have opportunities to expand your professional network
Get exposure to what it is like working in a Fortune 500 medical device company
Design, fabricate, and prototype new device designs to address clinical feedback
Assist new product development teams in device development and testing
Research and analyze, clinical and market data for new market opportunities
Qualification
Required
Must graduate between Fall 2026 and Spring 2028
Must have at least one semester of school left post-internship
Currently pursuing a degree in Mechanical Engineering, Chemical Engineering, or Biomedical Engineering
Must be able to commit to one of the following full internship program periods: May 18th – August 7th OR May 26th – August 14th
Must be eligible to work in the U.S. without company sponsorship, now or in the future, for employment-based work authorization
Must have reliable transportation to and from the Maple Grove, MN Boston Scientific Corporate location
Preferred
Excellent communication and collaboration with diverse cross-functional teams
Passionate to learn new technologies and find new solutions
Proactive problem solving skills
Benefits
Relocation and housing assistance may be available to those who meet the eligibility criteria.
Company
Boston Scientific
Boston Scientific is a medical technology company that designs and develops medical devices to diagnose and treat a wide range of condition.
Founded in 1979
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$10.02B2025-02-21Post Ipo Debt· $1.58B
2024-02-22Post Ipo Debt· $2.17B
2022-03-04Post Ipo Debt· $3.28B
Leadership Team
Michael Mahoney
Chairman, President & CEO
Daniel J. Brennan
Chief Financial Officer
Recent News
2026-01-24
2026-01-23
Company data provided by crunchbase